Shares of Aphria rose 3.65% to $7.38 at 14:38 EST on Wednesday, after two successive sessions in a row of losses. The Nasdaq Stock Market is jumping 0.15% to $12,827.40, following last session’s upward trend, This seems, up until now, a somewhat positive trend exchanging session today.
Aphria’s last close was $7.12, 20.33% under its 52-week high of $8.88.
Aphria’s Stock Yearly Top and Bottom Value
Aphria’s stock is valued at $7.38 at 14:38 EST, way under its 52-week high of $8.88 and way higher than its 52-week low of $1.95.
Aphria’s Moving Average
Aphria’s value is above its 50-day moving average of $6.94 and way higher than its 200-day moving average of $5.27.
Previous days news about Aphria
Aphria, tilray deal is a bet on euro pot: cannabis weekly. According to Bloomberg Quint on Sun Dec 20, "The region is particularly attractive for the hundreds of small Canadian players, who are struggling with an oversupply of raw flower and an uncertain path into the U.S. And the Aphria-Tilray deal could be the first of more Euro-centric transactions.", ""Putting our companies together creates the largest medical cannabis business in Europe, and prepares us if one day legalization happens in the EU," Aphria Chief Executive Officer Irwin Simon told me in a discussion about the deal last week."